• Strategic Viability Analysis in CD38 CAR-T Research: Mechani

  2026-07-30

  This thought-leadership article explores the mechanistic and translational implications of reliable cell viability assessment in advanced immunotherapy workflows. Drawing on recent structural studies of CD38-targeted CAR binders and the unique advantages of the 7-AAD Cell Viability Assay Kit, it provides strategic guidance for translational researchers seeking to optimize workflow precision, minimize experimental drift, and accelerate clinical impact in cell therapy research.

• Nile Red for Lipid Storage Dynamics: Protocols and Pitfalls

  2026-07-30

  Nile Red (Nile blue oxazone) empowers precise, selective intracellular lipid droplet staining with dual-emission capabilities. This guide delivers workflow enhancements, troubleshooting strategies, and evidence-backed insights for optimizing lipid metabolism research.

• 7-AAD Cell Viability Assay Kit: Precision in Necrosis Detect

  2026-07-29

  The 7-AAD Cell Viability Assay Kit empowers researchers with accurate, multiplexed detection of necrosis and apoptosis, especially in high-stakes CAR-T and immunotherapy workflows. Its superior spectral properties and robust compatibility with flow cytometry and fluorescence microscopy set it apart from traditional viability assays.

• Belinostat (PXD101): Applied Protocols for Epigenetic Cancer

  2026-07-29

  Belinostat (PXD101) empowers precision epigenetic modulation for cancer researchers, offering nanomolar pan-HDAC inhibition and robust reproducibility across bladder and prostate cancer models. This guide delivers actionable protocols, troubleshooting insights, and a translation of advanced in vitro evaluation methods for optimal experimental outcomes.

• Optimizing Cardiovascular Assays with Atrial Natriuretic Pep

  2026-07-28

  Discover how 'Atrial Natriuretic Peptide (ANP) (C49H84N20O15S), rat' (SKU A1009) enhances reproducibility and sensitivity in cardiovascular and cell viability assays. This scenario-driven article equips biomedical researchers and lab technicians with evidence-based guidance, revealing how APExBIO’s high-purity ANP streamlines workflows and supports robust data generation.

• PD 173074 (SKU A8253): Practical Guidance for FGFR1/VEGFR2 I

  2026-07-28

  This article delivers scenario-driven, evidence-based insights into using PD 173074 (SKU A8253) for robust FGFR signaling pathway inhibition in cancer research. It addresses real-world assay reproducibility, protocol optimization, and data interpretation challenges, guiding bench scientists to reliable experimental outcomes. Discover how PD 173074 from APExBIO meets the demands of modern cell-based and in vivo workflows.

• Disulfiram: Dopamine β-Hydroxylase Inhibitor for Cancer Rese

  2026-07-27

  Disulfiram's dual role as a dopamine β-hydroxylase inhibitor and proteasome modulator enables advanced synthetic lethality and apoptosis workflows, particularly in cancer research targeting APC-deficient tumors. APExBIO's Disulfiram product supports robust, reproducible experimental designs with well-defined solubility and dosing parameters.

• Miltefosine Drives Neutrophil Differentiation via Ras/MEK/ER

  2026-07-27

  This paper demonstrates that Miltefosine, known chemically as hexadecyl 2-(trimethylazaniumyl)ethyl phosphate, activates the Ras/MEK/ERK pathway to promote neutrophil differentiation and restore bone marrow function in models of leukopenia. These findings suggest a new therapeutic rationale for using Miltefosine in hematology, with implications for immunocompromised patients and those undergoing cancer therapy.

• Tomivosertib Inhibits MNK-eIF4E Signaling to Suppress Gliobl

  2026-07-26

  The reference study demonstrates that Tomivosertib, a selective MNK1/2 inhibitor, disrupts eIF4E phosphorylation, suppressing glioblastoma growth, survival, and angiogenesis. This work reveals the MNK-eIF4E pathway as a promising therapeutic target, including for overcoming chemoresistance in glioblastoma models.

• Low Molecular Weight Fucoidan Suppresses Ferroptosis in Pulm

  2026-07-25

  This study demonstrates that low molecular weight fucoidan (LMWF) from Laminaria japonica inhibits ferroptosis, thereby alleviating pulmonary fibrosis in a bleomycin-induced mouse model. The findings reveal a mechanistic link between LMWF treatment, mitochondrial protection, and the regulation of ferroptosis-associated pathways, advancing our understanding of potential therapeutic strategies for fibrotic lung diseases.

• Protein A/G Magnetic Beads: Practical Use and QC Guide

  2026-07-24

  Protein A/G Magnetic Beads provide a robust platform for antibody purification and immunoprecipitation workflows, minimizing non-specific binding in complex biological samples. These magnetic beads are unsuitable for diagnostic or clinical use and should be applied in controlled research contexts that require precise protein interaction analysis.

• Dual Luciferase Reporter Gene System: Precision in Gene Regu

  2026-07-24

  The Dual Luciferase Reporter Gene System delivers unmatched accuracy for gene expression regulation studies by simultaneously measuring two bioluminescent signals in a single sample. Its streamlined workflow and robust normalization empower high-throughput, reproducible transcriptional regulation analysis—especially in complex signaling pathways such as those found in plant immunity or lncRNA research.

• Prolonging Mouse Corneal Epithelial Proliferation via 6C Med

  2026-07-23

  This study introduces a novel 6C cell culture medium that significantly extends the proliferative capacity of mouse corneal epithelial cells (mCEC) in vitro and in vivo. By inhibiting epithelial-mesenchymal transition (EMT), the approach provides a foundation for more reliable epithelial sheet generation, advancing research and potential treatments for corneal injury and stem cell deficiency.

• RapaLink-1: Redefining mTOR Inhibition for Dormancy and Canc

  2026-07-23

  Explore how RapaLink-1, a third-generation mTOR inhibitor, uniquely enables durable mTORC1 inhibition for both embryonic dormancy and cancer research. This article offers a deeper analysis of its bivalent mechanism, experimental protocols, and practical impact compared to previous mTOR inhibitors.

• Dorsomorphin (Compound C): New Insights into AMPK and BMP4 P

  2026-07-22

  Dorsomorphin (Compound C) is a powerful tool for dissecting AMPK and BMP4 signaling in vascular and metabolic contexts. This article uniquely explores its application in endothelial dysfunction models, practical assay design, and emerging translational implications.

16234 records 1/1083 page Next 12345 下5页 Last page